Current Pediatric HIV Studies
The following lists current clinical trials available for children and adolescents
with HIV infection at the Clinical Center of the National Institutes of Health
in Bethesda, MD. Lodging for children and parent/guardian is provided at the
Children's Inn located on the NIH campus and transportation is provided following
protocol enrollment. The costs of all protocol-related medical care and services
are covered through the National Cancer Institute.
A Phase I Study of Tenofovir for Children
with HIV Infection
This is a study being conducted to evaluate the safety and tolerability of
tenofovir in children who require a change in their treatment for HIV because
the HIV has become resistant to other drugs or the other drugs are poorly
tolerated. Tenofovir was designed with the aim of inhibiting HIV that has
mutated in a way that makes it resistant to other drugs. This study is designed
to obtain information on the effectiveness of tenofovir toward treating resistant
HIV in children.
Short-Course
Chemotherapy AIDS-associated non-Hodgkin's Lymphoma: This
is a trial that explores the use of infusional chemotherapy combined
with the monoclonal antibody rituximab to determine if it is possible
to achieve long-term lymphoma remission with as few as 3 cycles of chemotherapy.
Eligible patients must be aged 13 years and older.
FOR ADDITIONAL INFORMATION AND PATIENT REFERRAL, PLEASE CALL (301) 402-1391
OR E-MAIL: PedHAMBref@mail.nih.gov
